These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 16278813

  • 1. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn- and CD22-independent pathways affecting BCR regulation and B cell survival.
    Ferry H, Crockford TL, Silver K, Rust N, Goodnow CC, Cornall RJ.
    Eur J Immunol; 2005 Dec; 35(12):3655-63. PubMed ID: 16278813
    [Abstract] [Full Text] [Related]

  • 2. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
    Tedder TF, Poe JC, Haas KM.
    Adv Immunol; 2005 Dec; 88():1-50. PubMed ID: 16227086
    [Abstract] [Full Text] [Related]

  • 3. Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.
    Gross AJ, Lyandres JR, Panigrahi AK, Prak ET, DeFranco AL.
    J Immunol; 2009 May 01; 182(9):5382-92. PubMed ID: 19380785
    [Abstract] [Full Text] [Related]

  • 4. Genetic evidence for Lyn as a negative regulator of IL-4 signaling.
    Janas ML, Hodgkin P, Hibbs M, Tarlinton D.
    J Immunol; 1999 Oct 15; 163(8):4192-8. PubMed ID: 10510355
    [Abstract] [Full Text] [Related]

  • 5. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
    Chan VW, Lowell CA, DeFranco AL.
    Curr Biol; 1998 May 07; 8(10):545-53. PubMed ID: 9601638
    [Abstract] [Full Text] [Related]

  • 6. CD22 regulates early B cell development in BOB.1/OBF.1-deficient mice.
    Samardzic T, Gerlach J, Muller K, Marinkovic D, Hess J, Nitschke L, Wirth T.
    Eur J Immunol; 2002 Sep 07; 32(9):2481-9. PubMed ID: 12207332
    [Abstract] [Full Text] [Related]

  • 7. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
    Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otipoby KL, Clark EA, Goodnow CC.
    Immunity; 1998 Apr 07; 8(4):497-508. PubMed ID: 9586639
    [Abstract] [Full Text] [Related]

  • 8. B cell defects in SLP65/BLNK-deficient mice can be partially corrected by the absence of CD22, an inhibitory coreceptor for BCR signaling.
    Gerlach J, Ghosh S, Jumaa H, Reth M, Wienands J, Chan AC, Nitschke L.
    Eur J Immunol; 2003 Dec 07; 33(12):3418-26. PubMed ID: 14635051
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells.
    Katagiri T, Ogimoto M, Hasegawa K, Arimura Y, Mitomo K, Okada M, Clark MR, Mizuno K, Yakura H.
    J Immunol; 1999 Aug 01; 163(3):1321-6. PubMed ID: 10415030
    [Abstract] [Full Text] [Related]

  • 11. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
    Horikawa K, Martin SW, Pogue SL, Silver K, Peng K, Takatsu K, Goodnow CC.
    J Exp Med; 2007 Apr 16; 204(4):759-69. PubMed ID: 17420266
    [Abstract] [Full Text] [Related]

  • 12. Engagement of the B-cell antigen receptor activates STAT through Lyn in a Jak-independent pathway.
    Wang L, Kurosaki T, Corey SJ.
    Oncogene; 2007 May 03; 26(20):2851-9. PubMed ID: 17146444
    [Abstract] [Full Text] [Related]

  • 13. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
    Jellusova J, Wellmann U, Amann K, Winkler TH, Nitschke L.
    J Immunol; 2010 Apr 01; 184(7):3618-27. PubMed ID: 20200274
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
    Satterthwaite AB, Lowell CA, Khan WN, Sideras P, Alt FW, Witte ON.
    J Exp Med; 1998 Sep 07; 188(5):833-44. PubMed ID: 9730885
    [Abstract] [Full Text] [Related]

  • 16. The activation and subsequent regulatory roles of Lyn and CD19 after B cell receptor ligation are independent.
    Xu Y, Beavitt SJ, Harder KW, Hibbs ML, Tarlinton DM.
    J Immunol; 2002 Dec 15; 169(12):6910-8. PubMed ID: 12471124
    [Abstract] [Full Text] [Related]

  • 17. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
    Hasegawa M, Fujimoto M, Poe JC, Steeber DA, Lowell CA, Tedder TF.
    J Immunol; 2001 Sep 01; 167(5):2469-78. PubMed ID: 11509585
    [Abstract] [Full Text] [Related]

  • 18. Abrogation of autoimmune disease in Lyn-deficient mice by the deletion of IL-5 receptor alpha chain gene.
    Moon BG, Takaki S, Nishizumi H, Yamamoto T, Takatsu K.
    Cell Immunol; 2004 Apr 01; 228(2):110-8. PubMed ID: 15219462
    [Abstract] [Full Text] [Related]

  • 19. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
    Luo W, Mayeux J, Gutierrez T, Russell L, Getahun A, Müller J, Tedder T, Parnes J, Rickert R, Nitschke L, Cambier J, Satterthwaite AB, Garrett-Sinha LA.
    J Immunol; 2014 Jul 15; 193(2):909-920. PubMed ID: 24929000
    [Abstract] [Full Text] [Related]

  • 20. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6.
    Tsantikos E, Oracki SA, Quilici C, Anderson GP, Tarlinton DM, Hibbs ML.
    J Immunol; 2010 Feb 01; 184(3):1348-60. PubMed ID: 20042579
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.